Semantic association fMRI impairments represent a potential schizophrenia biomarker

Schizophrenia Research

Volumn 145, Issue 1-3, 2013, Pages 20-26

  Jamadar, Sharna D ^a,c   Pearlson, Godfrey D ^a,b   O'Neil, Kasey M ^a   Assaf, Michal ^a,b  

^a INSTITUTE OF LIVING   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Biomarker; FMRI; Formal thought disorder; Positive and negative symptoms; Semantic association

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FIRST DEGREE RELATIVE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFERIOR PARIETAL LOBULE; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SEMANTIC ASSOCIATION RETRIEVAL TASK; TASK PERFORMANCE;

ADULT; ANALYSIS OF VARIANCE; ASSOCIATION LEARNING; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; RECURRENCE; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEMANTICS; YOUNG ADULT;

EID: 84875273587     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.12.029     Document Type: Article

References (35)

1. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia: methods, meanings and mechanisms. Arch. Gen. Psychiatry 1995, 52:341-351.
2. Assaf M., Calhoun V.D., Kuzu C.H., Kraut M.A., Rickin P.R., Hart J., Pearlson G.D. Neural correlats of the object-recall process in semantic memory. Psychiatry Res. 2006, 147:115-126.
3. Assaf M., Rivkin P.R., Kuzu C.H., Calhoun V.D., Kraut M.A., Groth K.M., et al. Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia. Biol. Psychiatry 2006, 59:452-459.
4. Binder J.R., Desai R.H. The neurobiology of semantic memory. Trends Cogn. Sci. 2011, 15:527-536.
5. Bleuler E. The basic symptoms of schizophrenia. Organisation and pathology of thought: selected sources 1919/1951, Columbia University Press, New York, NY. D. Rapaport (Ed.).
6. Brett M., Anton J.L., Valabregue R., Poline J.-B. Region of interest analysis using the MarsBar toolbox for SPM99. Presented at the 8th International Congress on Functional Mapping of the Buman Brain, June 2-6 2002, Sendai Japan 2002.
7. Carter C.S., Barch D.M., Bullmore E., Beiling J., Buchanan R.W., Butler P., et al. Cognitive neuroscience treatment research to improve cognition in schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol. Psychiatry 2011, 70:7-12.
8. First M.B. TheDSMseries and experiencewith DSM-IV. Psychopathology 2002, 35:67-71.
9. Freire L., Roche A., Magin J.F. What is the best similarity measure for motion correction in fMRI time series?. IEEE Trans. Med. Imaging 2002, 21:470-484.
10. Gonzalez-Blanch C., Rodrigues-Sanchzez J.M., Perez-Iglesias R., Pardo-Garcia G., Martinez-Garcia O., Vazquex-Barquero K.L., Crespo-Facorro B. First episode schizophrenia patients neurpsychologically within the normal limits: evidence of deterioration in speed of processing. Schizophr. Res. 2010, 119:18-26.
11. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
12. Harvey P.D., Davidson M. Schizophrenia: course over the lifetime. Neuropsychopharmacology: The Fifth Generation of Progress 2002, Lippincott, Williams & Wilkins, Philadephia, PA. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
13. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., Cooper J.E., Day R., Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organisation ten-country study. Psychol. Med. 1992, 20:1-97.
14. Jamadar S., Powers N.R., Meda S.A., Gelernter J., Gruen J.R., Pearlson G.D. Genetic influences of cortical gray matter in language-related regions in healthy controls and schizophrenia. Schizophr. Res. 2011, 129:141-148.
15. Jamadar, S., O'Neil, K., Pearlson, G.D., Ansari, M., Gill, A., Jagannathan, K., Assaf, M., in press. Impairments in semantic retrieval is associated with symptoms in schizophrenia but not bipolar disorder. Biol. Psychiatry.
16. Kay S.R., Fiszbeln A., Opler L.A. The positive and negative syndrome scale (PANSS). Schizophr. Bull. 1987, 12:483-496.
17. Ke M., Zou R., Shen H., Huang X., Zhou Z., Liu Z., Xue Z., Hu D. Bilateral functional asymmetry disparity in positive and negative schizophrenia revealed by resting state fMRI. Psychiatry Res. 2010, 182:30-39.
18. Kendler K.S., McGue M., Gruenberg A.M., Walsh D. Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders. Arch. Gen. Psychiatry 1995, 52:296-303.
19. Ketteler D., Ketteler S. Is schizophrenia "the price Homo sapiens pays for language"? Subcortical language processing as the missing link between evolution and language disorder in psychosis-A neurolinguistic approach. J. Neurolinguistics 2010, 23:342-353.
20. Kraut M.A., Kremen S., Segal J.B., Calhoun V.D., Moo L.R., Hart J. Object activation from features in the semantic system. J. Cogn. Neurosci. 2002, 14:24-36.
21. Kraut M.A., Calhoun V., Pitcock J.A., Cusick C., Hart J. Neural hybrid model of semantic object memory: implication from event-related timing using fMRI. J. Int. Neuropsychol. Soc. 2003, 9:1031-1040.
22. Kuperberg G.R. Language in schizophrenia Part 2: What can psycholinguistics bring to the study of schizophrenia. . . and vice versa?. Lang. Linguist. Compass. 2010, 4:590-604.
23. Kuperberg G.R. Language in schizophrenia. Part 1: An introduction. Language and Linguistics Compass 2010, 4:576-589.
24. Levy D.L., Coleman M.J., Sing S., Ji F., Matthysse S., Mendell N.R., Titone D. The genetic basis of thought disorder and language and communication disturbances in schizophrenia. J. Neurolinguistics 2010, 23:176-192.
25. Liddle P.F. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br. J. Psychiatry 1987, 151:145-151.
26. Liddle P.F. Syndromes of schizophrenia on factor analysis. Br. J. Psychiatry 1992, 161:861.
27. Meda S., Guilliani N.R., Calhoun V.D., Jagannathan K., Schretlen D.J., Pulver A., et al. A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr. Res. 2008, 101:95-105.
28. Messinger J.W., Tremeau D., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., Malaspina D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin. Psychol. Rev. 2011, 31:161-168.
29. Morrens M., Hulstijn W., Sabbe B. Psychomotor slowing in schizophrenia. Schizophr. Bull. 2007, 33:1038-1053.
30. Oertel V., Knochel C., Rotarska-Jagiela A., Schonmeyer R., Lindner M., et al. Reduced laterality as a trait marker of schizophrenia-evidence from structural and functional neuroimaging. J. Neurosci. 2010, 30:2289-2299.
31. Pearlson G.D., Petty R.G., Ross C.A., Tien A.Y. Schizophrenia: a disease of heteromodal association cortex?. Neuropsychopharmacology 1996, 14:1-17.
32. Solovay M.R., Shenton M.E., Gasperetti C., Coleman M., Kestnbaum E., Carpenter J.T., Holzman P.S. Scoring manual for the thought disorder index. Schizophr. Bull. 1986, 12:483-496.
33. Stahl S.M., Buckley P.F. Negative symptoms of schizophrenia: a problem that will not go away. Acta Psychiatr. Scand. 2007, 115:4-11.
34. Torrey E.F. Schizophrenia and the inferior parietal lobule. Schizophr. Res. 2007, 97:215-225.
35. Zhou S.Y., Suzuki M., Takahashi T., Hagino H., Kawasaki Y., Matsui M., et al. Parietal lobe volume deficits in schizophrenia spectrum disorders. Schizophr. Res. 2007, 89:35-48.